Insider Transactions in Q1 2025 at Gluco Track, Inc. (GCTK)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2025
|
John Ballantyne Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+50.0%
|
-
|
|
Mar 26
2025
|
Luis Malave Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,076
+1.42%
|
-
|
|
Mar 26
2025
|
Erin Catherine Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,896
+3.99%
|
-
|
|
Mar 26
2025
|
Allen Danzig Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,498
+43.8%
|
-
|
|
Mar 26
2025
|
Andrew K Balo Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,490
+50.0%
|
-
|
|
Mar 26
2025
|
Robert Fischell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,498
+42.28%
|
-
|
|
Mar 12
2025
|
John A. Ballantyne Revocable Living Trust Dated 08/01/2017 > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
2,560,553
+48.27%
|
-
|
|
Mar 12
2025
|
John Ballantyne Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,560,553
+48.27%
|
-
|
|
Mar 12
2025
|
Luis Malave Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
133,532
+48.54%
|
-
|
|
Mar 12
2025
|
Erin Catherine Carter Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
40,297
+47.95%
|
-
|
|
Mar 12
2025
|
Paul Goode Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
15,435
+44.84%
|
-
|
|
Feb 05
2025
|
Paul Goode Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
1,500
+29.68%
|
-
|